Alterations to the maternal circulating proteome after preeclampsia

Area of Science:

• Proteomics
• Cardiovascular Science
• Reproductive Medicine

Background:

• Preeclampsia (PE) is associated with long-term maternal risks including hypertension, heart disease, and metabolic syndrome.
• Detecting early signs of cardiovascular and metabolic disease postpartum is crucial for timely intervention.

Purpose of the Study:

• To investigate if a history of preeclampsia (PE) is associated with detectable alterations in the circulating maternal proteome six months postpartum.
• To identify potential proteomic markers for cardiovascular disease (CVD) risk in women with a history of PE.

Main Methods:

• Analysis of postpartum plasma samples from women with and without a history of PE using label-free liquid chromatography-mass spectrometry.
• Identification and comparison of peptides using the International Protein Index human database.
• Utilized exponentially modified protein abundance indices and pathway analysis software for data interpretation.

Main Results:

• Differential expression of peptides was observed between women with and without a history of PE.
• PE peptide profiles showed stronger associations with markers of coagulation, complement activation, and cardiovascular disease (CVD) functions.
• These proteomic alterations were evident even in PE subjects without traditional postpartum cardiovascular risk factors.

Conclusions:

• Circulating proteomic markers indicative of CVD risk and progression are present six months postpartum in women with a history of PE.
• Previous PE is associated with augmented circulating peptide profiles, even in the absence of clinically measurable cardiovascular risk.
• The findings support the implementation of postpartum prevention programs and identify potential molecular targets for screening and therapeutic interventions in the PE population.